Marks M, Schoones J W, Kolling C, Herren D B, Goldhahn J, Vliet Vlieland T P M
Department of Research and Development, Schulthess Klinik, Zurich, Switzerland.
J Hand Surg Eur Vol. 2013 Oct;38(8):822-38. doi: 10.1177/1753193413488301. Epub 2013 May 6.
The objective was to identify all outcome measures used in studies on trapeziometacarpal osteoarthritis (TMC OA) and evaluate their measurement properties. In a two-step systematic literature review, we first identified studies including TMC OA patients and extracted all outcome measures. They were categorized according to the Outcome Measures in Rheumatology (OMERACT) core set for OA including five dimensions: pain, physical function, global assessment, imaging, and quality of life (QoL). Secondly, we retrieved articles on the measurement properties of the identified outcome measures for TMC OA patients. First, 316 articles including 101 different outcome measures were identified, addressing the OMERACT pain and function domains most frequently but under-representing QoL. Second, 12 articles investigating measurement properties of 12 outcome measures were identified. The methodological quality of these studies was poor to fair, implying that based on the literature no recommendations to use any of the outcome measures can yet be made.
目的是识别在大多角骨-第一掌骨骨关节炎（TMC OA）研究中使用的所有结局指标，并评估其测量属性。在一项分两步进行的系统文献综述中，我们首先识别纳入TMC OA患者的研究，并提取所有结局指标。这些指标根据风湿病结局指标（OMERACT）骨关节炎核心集进行分类，该核心集包括五个维度：疼痛、身体功能、整体评估、影像学和生活质量（QoL）。其次，我们检索了关于已识别的TMC OA患者结局指标测量属性的文章。首先，识别出316篇文章，其中包含101种不同的结局指标，这些文章最常涉及OMERACT疼痛和功能领域，但对生活质量的描述不足。其次，识别出12篇研究12种结局指标测量属性的文章。这些研究的方法学质量为差到一般，这意味着基于现有文献，尚无法对使用任何结局指标给出推荐意见。
